Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 635.7 | 627.9 | 592.3 | 785.5 |
Revenue growth | 1.2% | 6.0% | -24.6% | |
Unit growth | 1.4% | | | |
Cost of goods sold | 358.0 | 336.5 | 306.5 | 414.5 |
Gross profit | 277.7 | 291.4 | 285.8 | 371.0 |
Gross margin | 43.7% | 46.4% | 48.3% | 47.2% |
Selling, general and administrative | 114.7 | 111.8 | 104.3 | 119.2 |
Other operating expenses | 216.4 | 197.3 | 182.4 | 192.7 |
EBITDA [+] | -12.9 | 20.3 | 38.8 | 98.1 |
EBITDA growth | -163.6% | -47.8% | -60.5% | |
EBITDA margin | -2.0% | 3.2% | 6.5% | 12.5% |
Depreciation and amortization | 40.6 | 38.0 | 39.7 | 39.1 |
EBIT [+] | -53.5 | -17.7 | -0.9 | 59.0 |
EBIT growth | 201.5% | 1842.5% | -101.5% | |
EBIT margin | -8.4% | -2.8% | -0.2% | 7.5% |
Non-recurring items [+] | 486.3 | 962.3 | | |
Asset impairment | 486.3 | 962.3 | | |
Interest expense | 45.3 | 46.3 | 69.3 | 77.0 |
Interest expense | 45.3 | 46.3 | 69.3 | 77.0 |
Other income (expense), net [+] | -5.1 | 102.4 | 74.0 | -60.4 |
Unrealized gain/loss on derivatives | -42.5 | -175.1 | | |
Change in fair value of warrants | -4.2 | -22.6 | | |
Other | -3.3 | -0.2 | 91.0 | -0.8 |
Pre-tax income | -590.1 | -923.9 | 3.8 | -78.3 |
Income taxes | -48.5 | -71.0 | 2.1 | -44.0 |
Tax rate | 8.2% | 7.7% | 53.9% | 56.2% |
Minority interest | -0.7 | -3.7 | 5.1 | 4.4 |
Net income | -540.9 | -849.3 | -3.3 | -38.7 |
Net margin | -85.1% | -135.3% | -0.6% | -4.9% |
|
Basic EPS [+] | ($2.66) | ($5.12) | ($0.03) | ($0.30) |
Growth | -48.0% | 19776.2% | -91.5% | |
Diluted EPS [+] | ($2.66) | ($5.12) | ($0.03) | ($0.30) |
Growth | -48.0% | 19776.2% | -91.5% | |
|
Shares outstanding (basic) [+] | 203.2 | 165.8 | 128.3 | 128.3 |
Growth | 22.5% | 29.2% | 0.0% | |
Shares outstanding (diluted) [+] | 203.2 | 165.8 | 128.3 | 128.3 |
Growth | 22.5% | 29.2% | 0.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|